首页 > 最新文献

Iranian Journal of Blood and Cancer最新文献

英文 中文
Angioimmunoblastic T-cell lymphoma associated with leukocytosis and lymphocytosis; a case report and systematic review 血管免疫母细胞t细胞淋巴瘤伴白细胞增多和淋巴细胞增多;一份病例报告和系统回顾
Q4 Medicine Pub Date : 2023-03-01 DOI: 10.58209/ijbc.15.1.36
Esmaeil Shahabi Satlsar, Saeid Anvari, F. Sotoudeh, Seyed Hossein Mirpour Hassankiadeh, Amirhossein Rastgar, Setare Kheyrandish
{"title":"Angioimmunoblastic T-cell lymphoma associated with leukocytosis and lymphocytosis; a case report and systematic review","authors":"Esmaeil Shahabi Satlsar, Saeid Anvari, F. Sotoudeh, Seyed Hossein Mirpour Hassankiadeh, Amirhossein Rastgar, Setare Kheyrandish","doi":"10.58209/ijbc.15.1.36","DOIUrl":"https://doi.org/10.58209/ijbc.15.1.36","url":null,"abstract":"","PeriodicalId":14581,"journal":{"name":"Iranian Journal of Blood and Cancer","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42995737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CRISPR/Cas9 technology: A promising gene-editing tool for the treatment of cancers CRISPR/Cas9技术:一种很有前途的癌症基因编辑工具
Q4 Medicine Pub Date : 2023-03-01 DOI: 10.58209/ijbc.15.1.60
Muhammad Khairi Ahmad, Kumitaa Theva Das, Siti Razila Abdul Razak
{"title":"CRISPR/Cas9 technology: A promising gene-editing tool for the treatment of cancers","authors":"Muhammad Khairi Ahmad, Kumitaa Theva Das, Siti Razila Abdul Razak","doi":"10.58209/ijbc.15.1.60","DOIUrl":"https://doi.org/10.58209/ijbc.15.1.60","url":null,"abstract":"","PeriodicalId":14581,"journal":{"name":"Iranian Journal of Blood and Cancer","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46136737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gold nanoparticles in radiation therapy: an old story yet mesmerizing 放射治疗中的金纳米粒子:一个古老而迷人的故事
Q4 Medicine Pub Date : 2022-12-01 DOI: 10.58209/ijbc.14.4.140
Yasamin Kavousi, Mohadeseh Mohammadi, Mahdieh Ahmadikamalabadi, Fereshteh Koosha
{"title":"Gold nanoparticles in radiation therapy: an old story yet mesmerizing","authors":"Yasamin Kavousi, Mohadeseh Mohammadi, Mahdieh Ahmadikamalabadi, Fereshteh Koosha","doi":"10.58209/ijbc.14.4.140","DOIUrl":"https://doi.org/10.58209/ijbc.14.4.140","url":null,"abstract":"","PeriodicalId":14581,"journal":{"name":"Iranian Journal of Blood and Cancer","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44133945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Mitochondrial DNA 4977-bp Deletion in Patients with Colorectal Cancer: a Case-control Study in Iran 伊朗大肠癌患者线粒体DNA 4977-bp缺失的病例对照研究
Q4 Medicine Pub Date : 2022-12-01 DOI: 10.58209/ijbc.14.4.104
Sharareh Kamfar, F. Alaei, R. Zaferani, Vahide Zeinali
{"title":"The Mitochondrial DNA 4977-bp Deletion in Patients with Colorectal Cancer: a Case-control Study in Iran","authors":"Sharareh Kamfar, F. Alaei, R. Zaferani, Vahide Zeinali","doi":"10.58209/ijbc.14.4.104","DOIUrl":"https://doi.org/10.58209/ijbc.14.4.104","url":null,"abstract":"","PeriodicalId":14581,"journal":{"name":"Iranian Journal of Blood and Cancer","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43875541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The evaluation of TLR1, TLR2, TLR4, TLR7, and TLR8 expression levels in the newly-diagnosed acute myeloid leukemia (AML) patients TLR1、TLR2、TLR4、TLR7和TLR8在新诊断的急性髓细胞白血病(AML)患者中表达水平的评估
Q4 Medicine Pub Date : 2022-12-01 DOI: 10.58209/ijbc.14.4.95
Kosar Fateh, Bahareh Kashani, Z. Hasanpour, Naser Shagerdi Esmaeli, Vahid Amiri, S. H. Ghaffari, D. Bashash
{"title":"The evaluation of TLR1, TLR2, TLR4, TLR7, and TLR8 expression levels in the newly-diagnosed acute myeloid leukemia (AML) patients","authors":"Kosar Fateh, Bahareh Kashani, Z. Hasanpour, Naser Shagerdi Esmaeli, Vahid Amiri, S. H. Ghaffari, D. Bashash","doi":"10.58209/ijbc.14.4.95","DOIUrl":"https://doi.org/10.58209/ijbc.14.4.95","url":null,"abstract":"","PeriodicalId":14581,"journal":{"name":"Iranian Journal of Blood and Cancer","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43893166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coagulopathies after vaccination against SARS-CoV-2: The sole solution might lead to another problem 接种SARS-CoV-2疫苗后的凝血病:唯一的解决方案可能会导致另一个问题
Q4 Medicine Pub Date : 2022-12-01 DOI: 10.58209/ijbc.14.4.125
Saeed Hassani, Meshkat Mesh Poortavakol, M. Sayyadi
The common reported adverse impacts of COVID-19 vaccination include the injection site's local reaction followed by various non-specific flu-like symptoms. Nevertheless, uncommon cases of vaccine-induced immune thrombotic thrombocytopenia (VITT) and cerebral venous sinus thrombosis (CVST) following viral vector vaccines (ChAdOx1 nCoV-19 vaccine, Ad26.COV2 vaccine) have been reported. This literature review was performed using PubMed and Google Scholar databases using appropriate keywords and their combinations: SARS-CoV-2, adenovirus, spike protein, thrombosis, thrombocytopenia, vaccine-induced immune thrombotic thrombocytopenia (VITT), NF-kappaB, adenoviral vector, platelet factor 4 (PF4), COVID-19 Vaccine, AstraZeneca COVID vaccine, ChAdOx1 nCoV-19 COVID vaccine, AZD1222 COVID vaccine, coagulopathy. The s and titles of each article were assessed by authors for screening and inclusion English reports about post-vaccine CVST and VITT in humans were also collected. Some SARS-CoV-2 vaccines based on viral vector, mRNA, or inactivated SARS-CoV-2 virus have been accepted and are being pragmatic global. Nevertheless, the recent augmented statistics of normally very infrequent types of thrombosis associated with thrombocytopenia have been stated, predominantly in the context of the adenoviral vector vaccine ChAdOx1 nCoV-19 from Astra Zeneca. The numerical prevalence of these side effects seems to associate with this particular vaccine type, i.e., adenoviral vector-based vaccines, but the meticulous molecular mechanisms are still not clear. The present review summarizes the latest data and hypotheses for molecular and cellular mechanisms into one integrated hypothesis demonstrating that coagulopathies, including thromboses, thrombocytopenia, and other associated side effects, are correlated to an interaction of the two components in the COVID-19 vaccine.Copyright © 2022, Iranian Pediatric Hematology and Oncology Society. All rights reserved.
常见的COVID-19疫苗接种不良反应包括注射部位的局部反应,随后出现各种非特异性流感样症状。然而,罕见的疫苗诱导的免疫性血栓性血小板减少症(VITT)和脑静脉窦血栓形成(CVST)在病毒载体疫苗(ChAdOx1 nCoV-19疫苗,Ad26)后。COV2疫苗)已被报道。使用PubMed和谷歌Scholar数据库进行文献综述,使用合适的关键词及其组合:SARS-CoV-2、腺病毒、刺突蛋白、血栓形成、血小板减少症、疫苗诱导的免疫性血小板减少症(VITT)、NF-kappaB、腺病毒载体、血小板因子4 (PF4)、COVID-19疫苗、阿斯利康COVID疫苗、ChAdOx1 nCoV-19 COVID疫苗、AZD1222 COVID疫苗、凝血功能障碍。作者对每篇文章的标题和标题进行了筛选和纳入,并收集了关于疫苗后人类CVST和VITT的英文报告。一些基于病毒载体、mRNA或灭活SARS-CoV-2病毒的SARS-CoV-2疫苗已被接受,并在全球范围内是实用的。然而,最近增加了与血小板减少症相关的通常非常罕见的血栓类型的统计数据,主要是在Astra Zeneca的腺病毒载体疫苗ChAdOx1 nCoV-19的背景下。这些副作用的数量流行率似乎与这种特殊的疫苗类型有关,即基于腺病毒载体的疫苗,但其细致的分子机制仍然不清楚。本综述将分子和细胞机制的最新数据和假设总结为一个综合假设,表明凝血功能障碍,包括血栓形成、血小板减少和其他相关副作用,与COVID-19疫苗中这两种成分的相互作用有关。版权所有©2022,伊朗儿童血液学和肿瘤学会。版权所有。
{"title":"Coagulopathies after vaccination against SARS-CoV-2: The sole solution might lead to another problem","authors":"Saeed Hassani, Meshkat Mesh Poortavakol, M. Sayyadi","doi":"10.58209/ijbc.14.4.125","DOIUrl":"https://doi.org/10.58209/ijbc.14.4.125","url":null,"abstract":"The common reported adverse impacts of COVID-19 vaccination include the injection site's local reaction followed by various non-specific flu-like symptoms. Nevertheless, uncommon cases of vaccine-induced immune thrombotic thrombocytopenia (VITT) and cerebral venous sinus thrombosis (CVST) following viral vector vaccines (ChAdOx1 nCoV-19 vaccine, Ad26.COV2 vaccine) have been reported. This literature review was performed using PubMed and Google Scholar databases using appropriate keywords and their combinations: SARS-CoV-2, adenovirus, spike protein, thrombosis, thrombocytopenia, vaccine-induced immune thrombotic thrombocytopenia (VITT), NF-kappaB, adenoviral vector, platelet factor 4 (PF4), COVID-19 Vaccine, AstraZeneca COVID vaccine, ChAdOx1 nCoV-19 COVID vaccine, AZD1222 COVID vaccine, coagulopathy. The s and titles of each article were assessed by authors for screening and inclusion English reports about post-vaccine CVST and VITT in humans were also collected. Some SARS-CoV-2 vaccines based on viral vector, mRNA, or inactivated SARS-CoV-2 virus have been accepted and are being pragmatic global. Nevertheless, the recent augmented statistics of normally very infrequent types of thrombosis associated with thrombocytopenia have been stated, predominantly in the context of the adenoviral vector vaccine ChAdOx1 nCoV-19 from Astra Zeneca. The numerical prevalence of these side effects seems to associate with this particular vaccine type, i.e., adenoviral vector-based vaccines, but the meticulous molecular mechanisms are still not clear. The present review summarizes the latest data and hypotheses for molecular and cellular mechanisms into one integrated hypothesis demonstrating that coagulopathies, including thromboses, thrombocytopenia, and other associated side effects, are correlated to an interaction of the two components in the COVID-19 vaccine.Copyright © 2022, Iranian Pediatric Hematology and Oncology Society. All rights reserved.","PeriodicalId":14581,"journal":{"name":"Iranian Journal of Blood and Cancer","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48797388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
“How should we treat older patients with Metastatic Colorectal Cancer, A Review” 《如何治疗老年转移性结直肠癌,综述》
Q4 Medicine Pub Date : 2022-12-01 DOI: 10.58209/ijbc.14.4.116
A. Colombo, C. Porretto, I. Fazio, T. Sciacchitano, Antonella Mazzonello
{"title":"“How should we treat older patients with Metastatic Colorectal Cancer, A Review”","authors":"A. Colombo, C. Porretto, I. Fazio, T. Sciacchitano, Antonella Mazzonello","doi":"10.58209/ijbc.14.4.116","DOIUrl":"https://doi.org/10.58209/ijbc.14.4.116","url":null,"abstract":"","PeriodicalId":14581,"journal":{"name":"Iranian Journal of Blood and Cancer","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43739229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood culture-negative infective endocarditis with thalassemia and neurological complication: A dangerous combination 血培养阴性感染性心内膜炎伴地中海贫血和神经系统并发症:一种危险的组合
Q4 Medicine Pub Date : 2022-12-01 DOI: 10.58209/ijbc.14.4.111
Novia Kusumawardhani, I. Dewi, L. K. Wardhani, Mohammad Budiarto
{"title":"Blood culture-negative infective endocarditis with thalassemia and neurological complication: A dangerous combination","authors":"Novia Kusumawardhani, I. Dewi, L. K. Wardhani, Mohammad Budiarto","doi":"10.58209/ijbc.14.4.111","DOIUrl":"https://doi.org/10.58209/ijbc.14.4.111","url":null,"abstract":"","PeriodicalId":14581,"journal":{"name":"Iranian Journal of Blood and Cancer","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46426733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Iranian Childhood Cancer Biobank 伊朗儿童癌症生物银行
Q4 Medicine Pub Date : 2022-12-01 DOI: 10.58209/ijbc.14.4.150
P. Eshghi, N. Dehghan-Nayeri, Maryam Kazemi Aghdam, Y. Nilipour, M. Rouzrokh, Z. Badiei, H. Farhangi, M. Noroozi, Hassan Reza Mohammadi, E. Moradi, S. Alavi, L. Mohajerzadeh, S. Shamsian, Ahmad Khaleghnejad Tabari, J. Ghoroubi, N. Momtazmanesh, M. Sarafi, R. Shojaeian, P. Dehghanian, Parastoo Molaei Tavana
{"title":"The Iranian Childhood Cancer Biobank","authors":"P. Eshghi, N. Dehghan-Nayeri, Maryam Kazemi Aghdam, Y. Nilipour, M. Rouzrokh, Z. Badiei, H. Farhangi, M. Noroozi, Hassan Reza Mohammadi, E. Moradi, S. Alavi, L. Mohajerzadeh, S. Shamsian, Ahmad Khaleghnejad Tabari, J. Ghoroubi, N. Momtazmanesh, M. Sarafi, R. Shojaeian, P. Dehghanian, Parastoo Molaei Tavana","doi":"10.58209/ijbc.14.4.150","DOIUrl":"https://doi.org/10.58209/ijbc.14.4.150","url":null,"abstract":"","PeriodicalId":14581,"journal":{"name":"Iranian Journal of Blood and Cancer","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46340787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The long-term outcome and efficacy of PR1/BCR-ABL multipeptides vaccination in chronic myeloid leukemia: results of a 7-year longitudinal investigation PR1/BCR-ABL多肽疫苗接种治疗慢性粒细胞白血病的长期疗效和疗效:一项为期7年的纵向研究结果
Q4 Medicine Pub Date : 2022-12-01 DOI: 10.58209/ijbc.14.4.84
S. H. Ghaffari, E. Osfouri, M. Ahmadvand, D. Bashash, P. Ghaffari, Ahmadreza Niavarani, E. Hossaini, M. Yaghmaie, Roghieh Koohi, Andisheh ie Ghashgha, A. Pourbagheri-Sigaroodi, S. Mousavi, K. Alimoghaddam, A. Ghavamzadeh
{"title":"The long-term outcome and efficacy of PR1/BCR-ABL multipeptides vaccination in chronic myeloid leukemia: results of a 7-year longitudinal investigation","authors":"S. H. Ghaffari, E. Osfouri, M. Ahmadvand, D. Bashash, P. Ghaffari, Ahmadreza Niavarani, E. Hossaini, M. Yaghmaie, Roghieh Koohi, Andisheh ie Ghashgha, A. Pourbagheri-Sigaroodi, S. Mousavi, K. Alimoghaddam, A. Ghavamzadeh","doi":"10.58209/ijbc.14.4.84","DOIUrl":"https://doi.org/10.58209/ijbc.14.4.84","url":null,"abstract":"","PeriodicalId":14581,"journal":{"name":"Iranian Journal of Blood and Cancer","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46397599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Iranian Journal of Blood and Cancer
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1